Principal Investigators: Dr. Joaquín Martínez from the CRIS Unit for Haematological Tumours. Centre: Hospital 12 de Octubre, Madrid Current situation Since the year 2013, the CRIS Cancer Foundation has been supporting the CRIS Unit for Haematological Tumours (HUNET-CRIS) at the Hospital 12 de October. The Unit is currently carrying out 130 clinical trials and has so far
Principal Investigators: Dr. Antonio Pérez and Cristina Ferreras from the CRIS Unit for Advanced Therapies. Centre: Hospital de La Paz, Madrid. Current situation In 2018, the CRIS Cancer Foundation funded the construction of the CRIS Unit on the 8th floor of the Maternity Wing at the Hospital Universitario de la Paz. Coordinated by Antonio Pérez Martinez, this
Principal Investigators: Dr Alberto Ocaña, Dr Atanasio Pandiella Centres: CHUA (University Hospital Complex of Albacete) – Albacete and CIC (Cancer Research Centre) – Salamanca Breast cancer is the most common cancer in the UK. Around 55,200 people are diagnosed with breast cancer every year in the UK. That is around 150 people a day. 15 out of 100 (15%)
CRIS is strongly committed to training medical and research personnel, with the goal of positioning itself as the global vanguard in cancer research and treatment. In 2017, the CRIS Foundation financed 10 research fellowships, lasting between six months and one year, to allow Spanish researchers travel to centres of reference abroad and acquire expertise
Principal Researcher: Dr David Olmos and Dr Elena Castro. Centres: Spanish National Cancer Research Centre (CNIO), IBIMA (Biomedical Research Institute of Malaga). Background: In the UK, about 1 in 8 men will be diagnosed with prostate cancer in their lifetime. Prostate cancer is the most common cancer in men. More than 47,500 men are diagnosed with
Researcher leading the project: Dr. Joaquín Martínez Centres developing the research: 12 de Octubre University Hospital, Madrid, Spanish National Cancer Research Centre (CNIO). Context Haematological, or blood cell tumours represent largely incurable cancers today. Blood cancer is the fifth most common cancer in the UK, with over 40,000 people being diagnosed with it every year. There are about
Participation of the Federation of Parents of Children with Cancer and leading national hospitals treating children with cancer: Niño Jesús Hospital, Sant Joan de Déu Hospital, Vall d’Hebrón University Hospital. Principal Investigator: Mayte Moreno Centres: INVESTEN, Health care research unit belonging to the Carlos III Institute. SUMMARY Children with cancer often suffer pain due to
Investigador Principal: Dr. Enrique de Álava Casado – Dra. Rosa Noguera Salvá Centres: Instituto de Investigaciones Sanitarias INCLIVA and Instituto de Biomedicina de Sevilla (IBiS) (Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla) Introduction: Sarcomas are tumours that arise from cells that make up the connective tissues that support the body. Round-cell sarcomas, in particular, often affect
Name of the Project: Research Project for MLL Leukaemia Principal Investigator: Dr Mireia Camós Centres: Sant Joan de Déu Hospital in Barcelona. Introduction: Paediatric acute leukaemias are the most common form of childhood cancer. Mixed-lineage leukaemia (MLL) in particular is a very aggressive type of leukaemia in children. Although we have seen improvements in the
Principal Researchers: Dr. Antonio Pérez. Centres: La Paz Hospital, 12 de Octubre Hospital in Madrid. Timeline: Phase 1:2014-2016 , Phase 2: 2016-2018 Background: Children’s cancer has had no relevant treatment improvements in the past few years, in spite of its being the first cause of childhood death in our country. Treatments applied to adults are not suitable,